Experience with selexipag in triple therapy for pulmonary arterial hypertension in Chinese children

Authors

Institutions

Publication Details

Journal
BMC Pediatrics
Published
2026-05-08
DOI
https://doi.org/10.1186/s12887-026-06954-9
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Experience with selexipag in triple therapy for pulmonary arterial hypertension in Chinese children

赵海朝, Y. Wang, W D Lu, X Cui et al.
BMC Pediatrics
Pulmonary Hypertension Research and Treatments
article

Experience with selexipag in triple therapy for pulmonary arterial hypertension in Chinese children

赵海朝, Y. Wang, W D Lu, X Cui, X Y Hu, Yuan Ji, Meng Li
article en

Abstract

No abstract available for this paper.
BMC Pediatrics
Shandong University (CN), Qilu Hospital of Shandong University (CN)
Natural Science Foundation of Shandong Province
Good health and well-being
Openalex Percentile: Top 6%
Pulmonary Hypertension Research and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Experience with selexipag in triple therapy for pulmonary arterial hypertension in Chinese children — 赵海朝, Y. Wang, et al. · BMC Pediatrics (2026) | TGRS Research Map | TGRS